Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of burden and depression among caregivers of relapsing-remitting MS patients in Spain: MS Feeling study.
Meca-Lallana J, Mendibe M, Hernández-Clares R, Caminero AB, Mallada-Frechin J, Dávila-Gonzalez P, Garcés-Redondo M, Gómez M, Millán-Pascual J, Soriano-Hernández G, Amigo-Jorrín Mdel C. Meca-Lallana J, et al. Among authors: mallada frechin j. Neurodegener Dis Manag. 2016 Aug;6(4):277-87. doi: 10.2217/nmt-2016-0014. Epub 2016 Aug 2. Neurodegener Dis Manag. 2016. PMID: 27480482
Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
Villaverde-González R, Candeliere-Merlicco A, Alonso-Frías MA, Aparicio Castro E, Carrillo Alcaraz A, Mallada Frechín J, Pérez Sempere Á. Villaverde-González R, et al. Among authors: mallada frechin j. Mult Scler Relat Disord. 2020 Nov;46:102518. doi: 10.1016/j.msard.2020.102518. Epub 2020 Sep 16. Mult Scler Relat Disord. 2020. PMID: 32977075
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
Barrero F, Mallada-Frechin J, Martínez-Ginés ML, Marzo ME, Meca-Lallana V, Izquierdo G, Ara JR, Oreja-Guevara C, Meca-Lallana J, Forero L, Sánchez-Vera I, Moreno MJ; in representation of the MS NEXT study investigators. Barrero F, et al. Among authors: mallada frechin j. PLoS One. 2020 Apr 2;15(4):e0230846. doi: 10.1371/journal.pone.0230846. eCollection 2020. PLoS One. 2020. PMID: 32240213 Free PMC article.
[The prevalence of multiple sclerosis in the Alcoi Health district].
Mallada-Frechín J, Matías-Guiu Guía J, Martín R, López-Arlandis JM, Camacho-Cuartero JM, Beltrán I, Moltó JM, Falip R, Abellán-Miralles I. Mallada-Frechín J, et al. Rev Neurol. 2000 Jun 16-30;30(12):1131-4. Rev Neurol. 2000. PMID: 10935237 Spanish.
[Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].
Mallada-Frechin J, Meca-Lallana V, Barrero F, Martinez-Gines ML, Marzo-Sola ME, Ricart J, Garcia E, En Representacion de Los Investigadores Del Estudio Ms Next ERLIDEMN. Mallada-Frechin J, et al. Rev Neurol. 2018 Sep 1;67(5):157-167. Rev Neurol. 2018. PMID: 30047118 Free article. Spanish.
Alcock canal syndrome secondary to endometrial infiltration.
Maestre-Verdú S, Medrano-Martínez V, Pack C, Fernández-Izquierdo S, Francés-Pont I, Mallada-Frechin J, Piqueras-Rodríguez L. Maestre-Verdú S, et al. Among authors: mallada frechin j. Neurologia. 2017 May;32(4):264-266. doi: 10.1016/j.nrl.2015.05.005. Epub 2015 Aug 21. Neurologia. 2017. PMID: 26304654 Free article. English, Spanish. No abstract available.
Eyelid myokymia in patients with migraine taking topiramate.
Medrano-Martínez V, Pérez-Sempere A, Moltó-Jordá JM, Fernández-Izquierdo S, Francés-Pont I, Mallada-Frechin J, Piqueras-Rodríguez L. Medrano-Martínez V, et al. Among authors: mallada frechin j. Acta Neurol Scand. 2015 Aug;132(2):143-6. doi: 10.1111/ane.12395. Epub 2015 Mar 31. Acta Neurol Scand. 2015. PMID: 25828425
25 results